Terms: = Head and neck cancer AND GATA3, HDR, 2625, ENSG00000107485, MGC5445, MGC5199, MGC2346 AND Treatment
241 results:
1. Interstitial brachytherapy for lip carcinomas: Comparison between Ir-192 low-dose-rate and high-dose-rate treatment.
Cuenin M; Salleron J; Peiffert D; Meknaci É; Gallet P; Abushama Y; Py JF; Renard S
Cancer Radiother; 2024 Apr; 28(2):145-151. PubMed ID: 38072744
[TBL] [Abstract] [Full Text] [Related]
2. Dosimetric comparison of postoperative interstitial high-dose-rate brachytherapy and modern external beam radiotherapy modalities in tongue and floor of the mouth tumours in terms of doses to critical organs.
Ferenczi Ö; Major T; Fröhlich G; Béla D; Tódor S; Polgár C; Akiyama H; Bukovszky B; Takácsi-Nagy Z
Radiol Oncol; 2023 Dec; 57(4):516-523. PubMed ID: 38038418
[TBL] [Abstract] [Full Text] [Related]
3. Salvage re-irradiation in non-melanoma skin cancers: A multicenter analysis.
Miszczyk M; Suleja A; Sobel S; Stec M; Chyrek AJ; Kolbusz M; Spałek M; Nasiek A; Stankiewicz M; Lelek P; Moll M; Kluska A; Kazalski D; Saniewski P; Kaminiów K; Burchardt WM; Wojcieszek P; Chicheł A; Cichoń P; Krzysztofiak T
Radiother Oncol; 2023 Dec; 189():109945. PubMed ID: 37806558
[TBL] [Abstract] [Full Text] [Related]
4. Detecting undetectable - epidemiology, etiology, and diagnosis of carcinoma of unknown primary - systematic review.
Ostojewska J; Wieczorek I; Pachciński O; Zdziennicki W; Burdan F
Folia Med Cracov; 2023 Apr; 63(1):19-37. PubMed ID: 37406274
[TBL] [Abstract] [Full Text] [Related]
5. High-dose-rate brachytherapy at 3 Gy per fraction for lip carcinoma: treatment outcomes and toxicity at 5-years.
Tuček L; Sirák I; Hodek M; Kašaová L; Grepl J; Paluska P; Pohanková D; Hruška L; Vošmik M; Petera J
Brachytherapy; 2023; 22(4):496-502. PubMed ID: 37015847
[TBL] [Abstract] [Full Text] [Related]
6. Repeat re-irradiation with interstitial hdr-brachytherapy for an in-field isolated nodal recurrence in a patient with HPV-positive squamous cell carcinoma of the head and neck.
Kim JK; Hardy-Abeloos C; Purswani JM; Kamen E; Concert CM; Duckworth T; Tam M; Haas J; Rybstein M; Vaezi A; Jacobson A; Hu KS
Brachytherapy; 2023; 22(4):503-511. PubMed ID: 36593130
[TBL] [Abstract] [Full Text] [Related]
7. The combination of volumetric arc radiation therapy and boost high-dose rate interstitial brachytherapy for T3N2c tongue cancer: a technical report.
Murakami N; Sakuramachi M; Kashihara T; Chiba T; Nakamura S; Ono K; Ueno T; Yoshimoto S; Yoshida K; Masui K; Akiyama H; Igaki H
Jpn J Clin Oncol; 2023 Jan; 53(1):85-90. PubMed ID: 36239100
[TBL] [Abstract] [Full Text] [Related]
8. Technical report: a high-dose-rate interstitial brachytherapy boost for residual sinonasal undifferentiated carcinoma.
Miyata Y; Murakami N; Honma Y; Mori T; Yoshimoto S; Kashihara T; Takemori M; Nakayama Y; Itami J; Ogo E; Igaki H
J Radiat Res; 2022 Dec; 63(6):879-883. PubMed ID: 36149017
[TBL] [Abstract] [Full Text] [Related]
9. Reirradiation for recurrent head and neck carcinoma using high-dose-rate brachytherapy: A multi-institutional study.
Yamazaki H; Masui K; Suzuki G; Yoshida K; Nakamura S; Isohashi F; Kotsuma T; Takaoka Y; Tanaka E; Akiyama H; Ishibashi N
Brachytherapy; 2022; 21(3):341-346. PubMed ID: 35307301
[TBL] [Abstract] [Full Text] [Related]
10. Results of sole postoperative interstitial, high-dose-rate brachytherapy of T1-2 tongue tumours.
Takácsi-Nagy Z; Ferenczi Ö; Major T; Akiyama H; Fröhlich G; Oberna F; Révész M; Poósz M; Polgár C
Strahlenther Onkol; 2022 Sep; 198(9):812-819. PubMed ID: 35157100
[TBL] [Abstract] [Full Text] [Related]
11. Left supraclavicular (Virchow's) node metastasis detected before primary infradiaphragmatic tumor: a case series.
Mochizuki Y; Tsuchiya M; Oyama J; Wada A; Kugimoto T; Kuroshima T; Hirai H; Tomioka H; Harada H; Ikeda T; Akashi T
J Med Case Rep; 2022 Jan; 16(1):33. PubMed ID: 35078521
[TBL] [Abstract] [Full Text] [Related]
12. Long term outcomes of Carcinoma Buccal Mucosa treated with High Dose Rate Interstitial Brachytherapy.
Bajwa HK; Singareddy R; Raju AK
Brachytherapy; 2022; 21(2):224-228. PubMed ID: 34876359
[TBL] [Abstract] [Full Text] [Related]
13. [The role of brachytherapy in the curative treatment of oral cavity tumors].
Ferenczi Ö; Major T; Takácsi-Nagy Z
Orv Hetil; 2021 Sep; 162(37):1471-1479. PubMed ID: 34516393
[TBL] [Abstract] [Full Text] [Related]
14. A Population-Based Analysis of Outpatient Thyroidectomy: Safe and Under-Utilized.
Noel CW; Griffiths R; Siu J; Forner D; Urbach D; Freeman J; Goldstein DP; Irish JC; Higgins KM; Devon K; Pasternak JD; Eskander A
Laryngoscope; 2021 Nov; 131(11):2625-2633. PubMed ID: 34378810
[TBL] [Abstract] [Full Text] [Related]
15. [Secretory carcinoma of salivary gland: a clinicopathological and prognostic analysis of twelve cases].
Cao YS; Lyu XQ
Zhonghua Bing Li Xue Za Zhi; 2021 Aug; 50(8):899-903. PubMed ID: 34344073
[No Abstract] [Full Text] [Related]
16. A review of dosimetric impact of implementation of model-based dose calculation algorithms (MBDCAs) for hdr brachytherapy.
Yousif YAM; Osman AFI; Halato MA
Phys Eng Sci Med; 2021 Sep; 44(3):871-886. PubMed ID: 34142317
[TBL] [Abstract] [Full Text] [Related]
17. Multidisciplinary approach to nose vestibule malignancies: setting new standards.
Bussu F; Tagliaferri L; Piras A; Rizzo D; Tsatsaris N; De Corso E; Parrilla C; Paludetti G
Acta Otorhinolaryngol Ital; 2021 Apr; 41(Suppl. 1):S158-S165. PubMed ID: 34060531
[TBL] [Abstract] [Full Text] [Related]
18. Differentially methylated genes in proliferative verrucous leukoplakia reveal potential malignant biomarkers for oral squamous cell carcinoma.
Herreros-Pomares A; Llorens C; Soriano B; Bagan L; Moreno A; Calabuig-Fariñas S; Jantus-Lewintre E; Bagan J
Oral Oncol; 2021 May; 116():105191. PubMed ID: 33657465
[TBL] [Abstract] [Full Text] [Related]
19. The AUGIS Survival Predictor: Prediction of Long-Term and Conditional Survival After Esophagectomy Using Random Survival Forests.
Rahman SA; Walker RC; Maynard N; Trudgill N; Crosby T; Cromwell DA; Underwood TJ;
Ann Surg; 2023 Feb; 277(2):267-274. PubMed ID: 33630434
[TBL] [Abstract] [Full Text] [Related]
20. Dose reduction in hdr brachytherapy of esophageal cancer using gold and gold alloy plaques: a Monte Carlo study.
Masoudi SF; Baratian S; Asadi S; Rasouli FS
Radiat Environ Biophys; 2021 Mar; 60(1):115-124. PubMed ID: 33389051
[TBL] [Abstract] [Full Text] [Related]
[Next]
